Louise Rodino-klapac - Net Worth and Insider Trading
Louise Rodino-klapac Net Worth
The estimated net worth of Louise Rodino-klapac is at least $8 Million dollars as of 2024-06-10. Louise Rodino-klapac is the Head of R&D, CSO of Sarepta Therapeutics Inc and owns about 65,678 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $8 Million. Details can be seen in Louise Rodino-klapac's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Louise Rodino-klapac has not made any transactions after 2021-11-24 and currently still holds the listed stock(s).
Transaction Summary of Louise Rodino-klapac
Louise Rodino-klapac Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Louise Rodino-klapac owns 1 companies in total, including Sarepta Therapeutics Inc (SRPT) .
Click here to see the complete history of Louise Rodino-klapac’s form 4 insider trades.
Insider Ownership Summary of Louise Rodino-klapac
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SRPT | Sarepta Therapeutics Inc | 2021-11-24 | Chief Scientific Officer |
Louise Rodino-klapac Latest Holdings Summary
Louise Rodino-klapac currently owns a total of 1 stock. Louise Rodino-klapac owns 65,678 shares of Sarepta Therapeutics Inc (SRPT) as of November 24, 2021, with a value of $8 Million.
Latest Holdings of Louise Rodino-klapac
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics Inc | 2021-11-24 | 65,678 | 122.88 | 8,070,513 |
Holding Weightings of Louise Rodino-klapac
Louise Rodino-klapac Form 4 Trading Tracker
According to the SEC Form 4 filings, Louise Rodino-klapac has made a total of 1 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Sarepta Therapeutics Inc is the acquisition of 3,780 shares on November 24, 2021, which cost Louise Rodino-klapac around $299,867.
Insider Trading History of Louise Rodino-klapac
- 1
Louise Rodino-klapac Trading Performance
GuruFocus tracks the stock performance after each of Louise Rodino-klapac's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Louise Rodino-klapac is -6.37%. GuruFocus also compares Louise Rodino-klapac's trading performance to market benchmark return within the same time period. The performance of stocks bought by Louise Rodino-klapac within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Louise Rodino-klapac's insider trading performs compared to the benchmark.
Performance of Louise Rodino-klapac
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.06 | | | | | |
| Relative Return to S&P 500(%) | 12.54 | | | | | |
Louise Rodino-klapac Ownership Network
Louise Rodino-klapac Owned Company Details
What does Sarepta Therapeutics Inc do?
Who are the key executives at Sarepta Therapeutics Inc?
Louise Rodino-klapac is the Chief Scientific Officer of Sarepta Therapeutics Inc. Other key executives at Sarepta Therapeutics Inc include Chief Tech Ops Officer Bilal Arif , Chief Financial Officer Ian Michael Estepan , and SVP & General Counsel Ryan Edward Brown .
Sarepta Therapeutics Inc (SRPT) Insider Trades Summary
Over the past 18 months, Louise Rodino-klapac made no insider transaction in Sarepta Therapeutics Inc (SRPT). Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net purchase of 68,532 shares made by Michael Andrew Chambers , a net sale of 30,000 shares made by Wigzell Hans Lennart Rudolf , and a net purchase of 50,000 shares made by Richard Barry .
In summary, during the past 3 months, insiders sold 4,396 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 0 shares, with a net sale of 4,396 shares. During the past 18 months, 42,731 shares of Sarepta Therapeutics Inc (SRPT) were sold and 143,757 shares were bought by its insiders, resulting in a net purchase of 101,026 shares.
Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sarepta Therapeutics Inc Insider Transactions
Louise Rodino-klapac Mailing Address
Above is the net worth, insider trading, and ownership report for Louise Rodino-klapac. You might contact Louise Rodino-klapac via mailing address: 215 First Street, Ste 415, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
